• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入鲑鱼降钙素在呼吸上皮屏障中的命运研究。

Investigations into the fate of inhaled salmon calcitonin at the respiratory epithelial barrier.

机构信息

School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.

出版信息

Pharm Res. 2012 Jan;29(1):332-41. doi: 10.1007/s11095-011-0553-z. Epub 2011 Aug 5.

DOI:10.1007/s11095-011-0553-z
PMID:21818710
Abstract

PURPOSE

The fate of inhaled salmon calcitonin (sCT) at the respiratory epithelial barrier was studied with particular emphasis on enzymatic degradation by trypsin, chymotrypsin, and neutrophil elastase.

METHODS

Degradation of sCT was assessed by HPLC in cell homogenate, supernatant and intact monolayers of human respiratory epithelial cells (hBEpC, Calu-3, 16HBE14o-, A549) and Caco-2 as comparison at 37°C for 2 h. Breakdown of sCT by trypsin, chymotrypsin and neutrophil elastase was investigated. The presence of enzymes in cell supernatant and homogenate was studied by immunoblot and enzyme activity by model substrate assay. Transport studies across Calu-3 monolayers were performed.

RESULTS

sCT concentration remained unchanged over 2 h, when incubated in supernatant or with cell monolayers, independent of cell type studied. When cell homogenates were used, sCT concentrations were reduced to varying extents. sCT was degraded when incubated with enzymes alone. Western blot revealed abundance of all proteinases in cell homogenates and weaker expression in supernatants. Transport studies indicated net-absorptive sCT translocation; presence of bacitracin resulted in increased amount of sCT in receiver compartments.

CONCLUSIONS

Epithelial proteases play a role in the disposition of sCT after pulmonary delivery.

摘要

目的

研究吸入鲑鱼降钙素(sCT)在呼吸上皮屏障中的命运,特别强调其被胰蛋白酶、糜蛋白酶和中性粒细胞弹性蛋白酶降解的情况。

方法

在 37°C 下孵育 2 小时,通过 HPLC 在人呼吸道上皮细胞(hBEpC、Calu-3、16HBE14o-、A549)和 Caco-2 的细胞匀浆、上清液和完整单层中评估 sCT 的降解情况,并进行比较。研究了 sCT 被胰蛋白酶、糜蛋白酶和中性粒细胞弹性蛋白酶分解的情况。通过免疫印迹研究细胞上清液和匀浆中酶的存在情况,通过模型底物测定法研究酶活性。进行 Calu-3 单层的转运研究。

结果

sCT 在孵育上清液或与细胞单层时,在 2 小时内浓度保持不变,与所研究的细胞类型无关。当使用细胞匀浆时,sCT 的浓度会被不同程度地降低。sCT 单独孵育时会被降解。Western blot 显示所有蛋白酶在细胞匀浆中的丰度较高,而在上清液中的表达较弱。转运研究表明 sCT 具有净吸收的转运;存在杆菌肽会导致接收室中 sCT 的量增加。

结论

上皮蛋白酶在 sCT 经肺部给药后的处置中发挥作用。

相似文献

1
Investigations into the fate of inhaled salmon calcitonin at the respiratory epithelial barrier.吸入鲑鱼降钙素在呼吸上皮屏障中的命运研究。
Pharm Res. 2012 Jan;29(1):332-41. doi: 10.1007/s11095-011-0553-z. Epub 2011 Aug 5.
2
In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.鲑鱼降钙素 PEG 脂质胶束复合物的体内外特性及其在肺部给药中的应用。
Pharm Res. 2012 Jun;29(6):1425-34. doi: 10.1007/s11095-012-0688-6. Epub 2012 Feb 10.
3
Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery.多种类卵黏蛋白对鲑鱼降钙素经丝氨酸蛋白酶分解的保护作用,用于口服给药。
J Pharm Sci. 2004 Feb;93(2):392-406. doi: 10.1002/jps.10557.
4
Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.评价 HPβCD-PEG 微粒经肺部给药用于鲑鱼降钙素的传递。
Mol Pharm. 2011 Oct 3;8(5):1887-98. doi: 10.1021/mp200231c. Epub 2011 Sep 15.
5
PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights.不同相对分子质量的梳状聚乙二醇化鲑鱼降钙素缀合物的 PK/PD 模型研究。
J Control Release. 2011 Jan 20;149(2):126-32. doi: 10.1016/j.jconrel.2010.10.004. Epub 2010 Oct 11.
6
The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.聚离子复合物胶束增强鲑鱼降钙素口服递送及其跨肠道上皮屏障的转运机制。
Biomaterials. 2012 Dec;33(34):8881-92. doi: 10.1016/j.biomaterials.2012.08.047. Epub 2012 Sep 10.
7
Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate.将鲑鱼降钙素与梳状末端功能化的聚(聚乙二醇甲基醚甲基丙烯酸酯)共轭可产生一种生物活性稳定共轭物。
J Control Release. 2009 Apr 2;135(1):51-9. doi: 10.1016/j.jconrel.2008.12.014. Epub 2009 Jan 8.
8
Preparation and evaluation of proliposomes containing salmon calcitonin.含鲑鱼降钙素的前体脂质体的制备与评价
J Control Release. 2002 Nov 7;84(1-2):27-37. doi: 10.1016/s0168-3659(02)00238-9.
9
Reverse transcription polymerase chain reaction (RT-PCR) analysis of proteolytic enzymes in cultures of human respiratory epithelial cells.人呼吸道上皮细胞培养物中蛋白酶的逆转录聚合酶链反应(RT-PCR)分析。
J Aerosol Med Pulm Drug Deliv. 2011 Apr;24(2):89-101. doi: 10.1089/jamp.2010.0842. Epub 2011 Mar 16.
10
Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.用于口服递送鲑鱼降钙素的含蛋白质-脂肪酸复合物的可生物降解纳米颗粒。
J Pharm Sci. 2004 Feb;93(2):488-95. doi: 10.1002/jps.10573.

引用本文的文献

1
Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins.增强吸入型肽和蛋白质系统性吸收的挑战与策略。
Pharm Res. 2023 May;40(5):1037-1055. doi: 10.1007/s11095-022-03435-3. Epub 2022 Nov 16.
2
Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitro.建立极化的人呼吸道上皮Calu-3细胞的液体覆盖培养体系以在体外研究宿主细胞对呼吸道病原体的反应。
J Vis Exp. 2013 Feb 7(72):50157. doi: 10.3791/50157.
3
In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.

本文引用的文献

1
Reverse transcription polymerase chain reaction (RT-PCR) analysis of proteolytic enzymes in cultures of human respiratory epithelial cells.人呼吸道上皮细胞培养物中蛋白酶的逆转录聚合酶链反应(RT-PCR)分析。
J Aerosol Med Pulm Drug Deliv. 2011 Apr;24(2):89-101. doi: 10.1089/jamp.2010.0842. Epub 2011 Mar 16.
2
The particle has landed--characterizing the fate of inhaled pharmaceuticals.粒子已经着陆——描述吸入式药物的命运。
J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S71-87. doi: 10.1089/jamp.2010.0836.
3
Emerging drugs for postmenopausal osteoporosis.
鲑鱼降钙素 PEG 脂质胶束复合物的体内外特性及其在肺部给药中的应用。
Pharm Res. 2012 Jun;29(6):1425-34. doi: 10.1007/s11095-012-0688-6. Epub 2012 Feb 10.
绝经后骨质疏松症的新型药物
Expert Opin Emerg Drugs. 2009 Mar;14(1):129-44. doi: 10.1517/14728210902766813.
4
Advances in peptide pharmaceuticals.肽类药物的进展。
Curr Pharm Biotechnol. 2009 Jan;10(1):122-37. doi: 10.2174/138920109787048634.
5
In vitro cell culture models for the assessment of pulmonary drug disposition.用于评估肺部药物处置的体外细胞培养模型。
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):333-45. doi: 10.1517/17425255.4.4.333.
6
A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin.鲑鱼降钙素粉末和气雾剂剂型的肺部生物利用度比较。
Pharm Res. 2008 Jul;25(7):1583-90. doi: 10.1007/s11095-008-9547-x. Epub 2008 Feb 21.
7
Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection.提高位点特异性聚乙二醇化鲑鱼降钙素的肺内递送:通过聚乙二醇大小选择进行优化。
J Control Release. 2008 Jan 4;125(1):68-75. doi: 10.1016/j.jconrel.2007.10.008. Epub 2007 Oct 22.
8
Inhaling medicines: delivering drugs to the body through the lungs.吸入药物:通过肺部将药物输送到体内。
Nat Rev Drug Discov. 2007 Jan;6(1):67-74. doi: 10.1038/nrd2153.
9
Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.通过赖氨酸18位胺特异性聚乙二醇化改善鲑鱼降钙素的肠道递送:稳定性、渗透性、药代动力学行为及体内降钙作用疗效
J Control Release. 2006 Sep 12;114(3):334-42. doi: 10.1016/j.jconrel.2006.06.007. Epub 2006 Jun 14.
10
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.从含有胆盐的前体脂质体中增强鲑鱼降钙素(sCT)的肠道吸收。
J Control Release. 2005 Sep 2;106(3):298-308. doi: 10.1016/j.jconrel.2005.05.016.